References are publications that support the biological activity of the product
Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
Strobl JS et al (2009) J Parasitol 95(1) : 215-23.
Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells.
Martirosyan A et al (2006) J Pharmacol Exp Ther 317(2) : 546-52.